EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Comprehensive registry of esophageal cancer in Japan, 2016

Yasue Kimura, Akihiko Okamura, Masashi Takeuchi, Hiroyuki Yamamoto, Hiroshi Saeki, Masayuki Watanabe, Ryu Ishihara, Masaki Ueno, Takashi Uno, Tsuneo Oyama, Koji Kono, Koji Tanaka und 11 weitere

Esophagus · 2025

DOI: 10.1007/s10388-025-01141-8 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Esophagus, 2025. Verfasst von Yasue Kimura und 22 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterological Surgery, National Hospital Organization Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Registries, Adenocarcinoma, Carcinoma, Squamous Cell. Die Arbeit wurde bisher 28-mal zitiert (Crossref) und nennt 3 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The registration committee for esophageal cancer in the Japan Esophageal Society (JES) has collected the characteristics, treatments, and outcomes of patients who underwent any treatment in 2016 in Japan.

Methods

We analyzed data on patients who had visited the participating hospitals in 2016. We collected the data using the National Clinical Database with a web-based data collection system. We used the Japanese Classification of Esophageal Cancer 11th edition by JES and the TNM Classification 8th edition by the Union of International Cancer Control (UICC) for cancer staging. Two committee members (A. O. and M. T.), endorsed by the Japan Esophageal Society and certified by the NCD, analyzed the data.

Results

A total of 9,593 cases were registered from 347 institutions in Japan. Squamous cell carcinoma (SCC) and adenocarcinoma accounted for 87.5% and 7.2%, respectively. The 5-year survival rates of patients treated by endoscopic resection, concurrent chemoradiotherapy, radiotherapy alone, and esophagectomy were 89%, 36%, 26%, and 59%, respectively. Esophagectomy was performed in 4,988 cases. Minimally invasive approaches were selected for 65.1%, and 57.7% underwent thoracoscopic esophagectomy. The 5-year survival rates of esophagectomy cases with pStage 0, I, II, III, IVa, and IVb in the JES system were 83%, 79%, 67%, 40%, 34%, and 27%, respectively. In the UICC system, the survival of surgically resected SCC cases with pStage IVB, mainly due to supraclavicular lymph-node metastasis, was better than that with pStage IVA.

Conclusion

We hope that this report improves all aspects of diagnosing and treating esophageal cancer in Japan.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Esophageal NeoplasmsRegistriesAdenocarcinomaCarcinoma, Squamous CellHumansJapanMaleFemaleEsophagectomyAgedMiddle AgedNeoplasm StagingSurvival RateChemoradiotherapyAged, 80 and overAdult

Stichwörter der Autor:innen

ChemotherapyComprehensive registryEndoscopic treatmentEsophageal cancerEsophagectomyRadiotherapy

Autor:innen und Institutionen

  • Department of Gastroenterological Surgery, National Hospital Organization Kyushu Cancer Center, 3-1-1 Notame, Minami-ku, Fukuoka, 811-1395, Japan.
  • Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan.
  • Department of Surgery, Keio University School of Medicine, 35 Shinanomachi, Shinjyku-ku, Tokyo, 160-8582, Japan.
  • Department of Healthcare Quality Assessment, Graduate School of Medicine, The University of Tokyo, 7-3-1 Hongo, Bunkyo-ku, Tokyo, 113-8655, Japan.
  • Department of General Surgical Science, Graduate School of Medicine, Gunma University, 3-39-22 Showa-Machi, Maebashi, Gunma, 371-8511, Japan.
  • Department of Gastroenterological Surgery, Cancer Institute Hospital of Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo, 135-8550, Japan. masayuki.watanabe@jfcr.or.jp.

Zitieren

APA

Kimura, Y., Okamura, A., Takeuchi, M., Yamamoto, H., Saeki, H., Watanabe, M., Ishihara, R., Ueno, M., Uno, T., Oyama, T., Kono, K., Tanaka, K., Tsushima, T., Toyozumi, T., Numasaki, H., Matsubara, H., Miyazaki, T., Muro, K., Morita, M., …, & Registration Committee for Esophageal Cancer of the Japan Esophageal Society (2025). Comprehensive registry of esophageal cancer in Japan, 2016. Esophagus. https://doi.org/10.1007/s10388-025-01141-8

Vancouver

Kimura Y, Okamura A, Takeuchi M, Yamamoto H, Saeki H, Watanabe M, et al. Comprehensive registry of esophageal cancer in Japan, 2016. Esophagus. 2025. doi:10.1007/s10388-025-01141-8

BibTeX
@article{Kimura2025,
  author = {Kimura, Yasue and Okamura, Akihiko and Takeuchi, Masashi and Yamamoto, Hiroyuki and Saeki, Hiroshi and Watanabe, Masayuki and Ishihara, Ryu and Ueno, Masaki and Uno, Takashi and Oyama, Tsuneo and Kono, Koji and Tanaka, Koji and Tsushima, Takahiro and Toyozumi, Takeshi and Numasaki, Hodaka and Matsubara, Hisahiro and Miyazaki, Tatsuya and Muro, Kei and Morita, Masaru and Yamamoto, Shun and Yoshio, Toshiyuki and Takeuchi, Hiroya and Registration Committee for Esophageal Cancer of the Japan Esophageal Society, Registration Committee for Esophageal Cancer of the Japan Esophageal Society},
  title = {Comprehensive registry of esophageal cancer in Japan, 2016},
  journal = {Esophagus},
  year = {2025},
  doi = {10.1007/s10388-025-01141-8}
}
Kostenlos starten →